For the preventive treatment of migraine in adults.
For the preventive treatment of migraine in adults.
For the preventive treatment of migraine in adults.
For the preventive treatment of migraine in adults.
How well VYEPTI works to prevent migraine attacks in the strict environment of a clinical study.
1072 people with chronic migraine and 665 people with episodic migraine.
People took either VYEPTI 100 mg, VYEPTI 300 mg, or placebo. No one in the study knew which dose they were taking.
who averaged 16 migraine days a month taking VYEPTI* had an average of
who averaged 9 migraine days a month taking VYEPTI* had an average of
*VYEPTI 100 mg or 300 mg
*VYEPTI 100 mg or 300 mg
How well VYEPTI works to prevent migraine attacks over 3 months (1 dose) in the strict environment of a clinical study.
1072 people with chronic migraine and 665 people with episodic migraine.
People received either VYEPTI 100 mg, VYEPTI 300 mg, or placebo. No one in the study knew which dose they were receiving.
who averaged 16 migraine days a month receiving VYEPTI* had an average of
vs 6 with placebo, over 3 months
*VYEPTI 100 mg or 300 mg
Chronic migraine is characterized by 15 or more headache days per month, with at least 8 of those being migraine days.
who averaged 9 migraine days a month receiving VYEPTI* had an average of
vs 3 with placebo, over 3 months
*VYEPTI 100 mg or 300 mg
Episodic migraine is characterized by 4 to 14 headache days per month, with at least 4 of those being migraine days.
Up to 40% of people who averaged 16 migraine days a month achieved
40% on VYEPTI 300 mg, 35% on VYEPTI 100 mg, and 22% on placebo had zero migraine days for a month or more.
*This analysis was not part of the original study plan and was initiated after the study ended, so we cannot make any firm conclusions based on these results.
†28 days in a row.
Study the safety of VYEPTI 300 mg and other patient-reported results over 2 years.
128 people with chronic migraine.
Everyone in the study knew they were receiving VYEPTI 300 mg, which may have influenced the results.
*Based on a question asking people how they feel about change in their overall migraine status, ranging from very much worse/much worse to much improved/very much improved. Improvement includes much improved or very much improved.
†Based on a questionnaire developed to measure the disability headaches cause in people's lives. Results were measured by the number of disability days reported in the past 3 months. Engaged in life was defined to include little or no disability (0-5 disability days reported).
Adults pictured in images above are real VYEPTI patients who were compensated for their time. These patients did not participate in the study.
Study the safety of VYEPTI 300 mg and other patient-reported results over 2 years.
128 people with chronic migraine.
Everyone in the study knew they were receiving VYEPTI 300 mg, which may have influenced the results.
*Based on a question asking people how they feel about change in their overall migraine status, ranging from very much worse/much worse to much improved/very much improved. Improvement includes much improved or very much improved.
†Based on a questionnaire developed to measure the disability headaches cause in people's lives. Results were measured by the number of disability days reported in the past 3 months. Engaged in life was defined to include little or no disability (0-5 disability days reported).
Adults pictured in images above are real VYEPTI patients who were compensated for their time. These patients did not participate in the study.
Stephanie, VYEPTI patient
Individual results may vary. Stephanie was compensated for her time.
Swipe for more
These survey results show how satisfied real people outside of a clinical setting are with VYEPTI in their day-to-day lives.
Before your next appointment, create your own Doctor Discussion Guide with personalized responses specific to your concerns and experience with migraine.
Do not receive VYEPTI if you have a known allergy to eptinezumab-jjmr or its ingredients.
VYEPTI is a prescription medicine used for the preventive treatment of migraine in adults.
VYEPTI may cause serious side effects such as:
Before starting VYEPTI, tell your healthcare provider about all your medical conditions, including if you have high blood pressure; circulation problems in your fingers and toes; are pregnant or plan to become pregnant; or are breastfeeding or plan to breastfeed.
Tell your healthcare provider about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements.
The most common side effects of VYEPTI include stuffy nose and scratchy throat, and allergic reactions. These are not all the possible side effects of VYEPTI. Tell your healthcare provider if you have any side effect that bothers you or that does not go away.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
For more information, please see the Prescribing Information and Patient Information.
VYEPTI is a prescription medicine used for the preventive treatment of migraine in adults.
Do not receive VYEPTI if you have a known allergy to eptinezumab-jjmr or its ingredients.
VYEPTI may cause serious side effects such as:
Before starting VYEPTI, tell your healthcare provider about all your medical conditions, including if you have high blood pressure; circulation problems in your fingers and toes; are pregnant or plan to become pregnant; or are breastfeeding or plan to breastfeed.
Tell your healthcare provider about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements.
The most common side effects of VYEPTI include stuffy nose and scratchy throat, and allergic reactions. These are not all the possible side effects of VYEPTI. Tell your healthcare provider if you have any side effect that bothers you or that does not go away.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
For more information, please see the Prescribing Information and Patient Information.
Have you been prescribed VYEPTI?
Your response will help us share information most relevant to you.
